-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Rani Therapeutics Holdings, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q3 2021 to Q3 2025.
- Rani Therapeutics Holdings, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 46,444,000, a 61% increase year-over-year.
- Rani Therapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 28,476,000, a 12% increase from 2023.
- Rani Therapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 25,505,000, a 7.1% increase from 2022.
- Rani Therapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 23,817,000.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)